PHOSPHOTOPE Drug Patent Profile
✉ Email this page to a colleague
When do Phosphotope patents expire, and what generic alternatives are available?
Phosphotope is a drug marketed by Bracco and is included in one NDA.
The generic ingredient in PHOSPHOTOPE is sodium phosphate p-32. There are one thousand four hundred and seventy-two drug master file entries for this compound. Additional details are available on the sodium phosphate p-32 profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PHOSPHOTOPE?
- What are the global sales for PHOSPHOTOPE?
- What is Average Wholesale Price for PHOSPHOTOPE?
Summary for PHOSPHOTOPE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 4 |
| DailyMed Link: | PHOSPHOTOPE at DailyMed |
US Patents and Regulatory Information for PHOSPHOTOPE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bracco | PHOSPHOTOPE | sodium phosphate p-32 | SOLUTION;INJECTION, ORAL | 010927-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
